Literature DB >> 11799154

Variables affecting in vivo performance of high-capacity adenovirus vectors.

Gudrun Schiedner1, Sabine Hertel, Marion Johnston, Volker Biermann, Volker Dries, Stefan Kochanek.   

Abstract

In high-capacity adenovirus (HC-Ad) vectors the size and/or composition of the vector genome influences vector stability during production and the expression profile following gene transfer. Typically, an HC-Ad vector will contain both a gene or an expression cassette and stuffer DNA that is required to balance the final vector genome to a size of between 27 and 36 kb. To gain an improved understanding of factors that may influence gene expression from HC-Ad vectors, we have generated a series of vectors that carry different combinations of human alpha-1 antitrypsin (hAAT) expression constructs and stuffer DNAs. Expression in vitro did not predict in vivo performance: all vectors expressed hAAT at similar levels when tested in cell culture. Hepatic expression was evaluated following in vivo gene transfer in C57BL/6J mice. hAAT levels obtained from genomic DNA were significantly higher than levels achieved with small cDNA expression cassettes. Expression was independent of the orientation and only marginally influenced by the location of the expression cassette within the vector genome. The use of lambda stuffer DNA resulted in low-level but stable expression for at least 3 months when higher doses were applied. A potential matrix attachment region element was identified within the hAAT gene and caused a 10-fold increase in expression when introduced in an HC-Ad vector genome carrying a phosphoglycerate kinase (pgk) hAAT cDNA construct. We also illustrate the influence of the promoter on anti-hAAT antibody formation in C57BL/6J mice: a human cytomegalovirus but not a pgk promoter resulted in an anti-hAAT antibody response. Thus, the overall design of HC-Ad vectors may significantly influence amounts and duration of gene expression at different levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799154      PMCID: PMC135880          DOI: 10.1128/jvi.76.4.1600-1609.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Differential influence of the E4 adenoviral genes on viral and cellular promoters.

Authors:  L Grave; D Dreyer; A Dieterle; P Leroy; A I Michou; C Doderer; A Pavirani; M Lusky; M Mehtali
Journal:  J Gene Med       Date:  2000 Nov-Dec       Impact factor: 4.565

2.  Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production.

Authors:  G Schiedner; S Hertel; S Kochanek
Journal:  Hum Gene Ther       Date:  2000-10-10       Impact factor: 5.695

3.  Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells.

Authors:  L Murray; M Travis; K Luens-Abitorabi; K Olsson; I Plavec; S Forestell; E G Hanania; B Hill
Journal:  Hum Gene Ther       Date:  2000-09-20       Impact factor: 5.695

4.  High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.

Authors:  N Morral; R J Parks; H Zhou; C Langston; G Schiedner; J Quinones; F L Graham; S Kochanek; A L Beaudet
Journal:  Hum Gene Ther       Date:  1998-12-10       Impact factor: 5.695

5.  The structure and expression of two defective adenovirus 2/simian virus 40 hybrids.

Authors:  J A Hassell; E Lukanidin; G Fey; J Sambrook
Journal:  J Mol Biol       Date:  1978-04-05       Impact factor: 5.469

6.  Automated DNA sequencing of the human HPRT locus.

Authors:  A Edwards; H Voss; P Rice; A Civitello; J Stegemann; C Schwager; J Zimmermann; H Erfle; C T Caskey; W Ansorge
Journal:  Genomics       Date:  1990-04       Impact factor: 5.736

7.  Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector.

Authors:  D Maione; M Wiznerowicz; P Delmastro; R Cortese; G Ciliberto; N La Monica; R Savino
Journal:  Hum Gene Ther       Date:  2000-04-10       Impact factor: 5.695

8.  Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster.

Authors:  S M Gasser; U K Laemmli
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

9.  Yeast ARS function and nuclear matrix association coincide in a short sequence from the human HPRT locus.

Authors:  R C Sykes; D Lin; S J Hwang; P E Framson; A C Chinault
Journal:  Mol Gen Genet       Date:  1988-05

10.  Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters.

Authors:  L E Babiss; J M Friedman; J E Darnell
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

View more
  11 in total

1.  Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.

Authors:  M Puntel; J F Curtin; J M Zirger; A K M Muhammad; W Xiong; C Liu; J Hu; K M Kroeger; P Czer; S Sciascia; S Mondkar; P R Lowenstein; M G Castro
Journal:  Hum Gene Ther       Date:  2006-05       Impact factor: 5.695

2.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

3.  Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10.

Authors:  Nagadhara Dronadula; Bradley K Wacker; Reginald Van Der Kwast; Jingwan Zhang; David A Dichek
Journal:  Hum Gene Ther       Date:  2016-11-14       Impact factor: 5.695

4.  Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia.

Authors:  Rongying Li; Hsu Chao; Kerry W S Ko; Shelley Cormier; Carrie Dieker; Elie A Nour; Shining Wang; Lawrence Chan; Kazuhiro Oka
Journal:  J Genet Syndr Gene Ther       Date:  2011-09-28

5.  Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.

Authors:  N Dronadula; L Du; R Flynn; J Buckler; J Kho; Z Jiang; S Tanaka; D A Dichek
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

6.  Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.

Authors:  Francesco Vetrini; Philip Ng
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

7.  Viral hybrid vectors for somatic integration - are they the better solution?

Authors:  Nadine Müther; Nadja Noske; Anja Ehrhardt
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

Review 8.  The adenovirus genome contributes to the structural stability of the virion.

Authors:  Bratati Saha; Carmen M Wong; Robin J Parks
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

9.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

Review 10.  The role of chromatin in adenoviral vector function.

Authors:  Carmen M Wong; Emily R McFall; Joseph K Burns; Robin J Parks
Journal:  Viruses       Date:  2013-06-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.